| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $243K | +30.5% | -2.9% |
| SG&A Expense | $277K | +31.5% | -46.0% |
| Pre-tax Income | -$489K | -107.0% | +64.7% |
| Net Income | -$489K | -107.1% | +64.7% |
| EPS (Basic) | -$0.38 | -222.6% | -442.9% |
| EPS (Diluted) | -$0.38 | -222.6% | -442.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $10.5M | -1.9% | +36.2% |
| Total Assets | $10.6M | -1.9% | +28.5% |
| Current Liabilities | $1.4M | +13.7% | -65.3% |
| Total Liabilities | $1.4M | +4.9% | -65.4% |
| Stockholders' Equity | $9.2M | -2.9% | +123.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | — |
| Capital Expenditures | $16K | — | — |
| Investing Cash Flow | -$16K | — | — |
| Financing Cash Flow | $1.0M | — | — |
| Free Cash Flow | -$1.4M | — | — |